(Total Views: 539)
Posted On: 09/28/2020 4:14:53 PM
Post# of 145880
![Avatar](https://investorshangout.com/images/ProfileImages/167738657_59587_mando klein.jpg)
Re: onestepahead #58250
No. That is a multi-disciplinary review of the monotherapy data requested by the BEFORE the actual re-submission. It will make sure we won't get another RTF for the same or similar issues, but otherwise offers no time advantage for us.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)